[Source: Antimicrobial Agents and Chemotherapy, full page: (LINK). Abstract, edited.]
Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates ofAcinetobacter baumannii from a Chinese university h...
12 results in 0.0384 seconds.
-
Antimicrob Agents Chemother. Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates ofAcinetobacter baumannii from a Chinese university hospital
-
Antimicrob Agents Chemother. Emergence of tigecycline resistance among multidrug-resistant Klebsiella pneumoniae: A nested case-control study
[Source: Antimicrobial Agents and Chemotherapy, full page: (LINK). Abstract, edited.]
Emergence of tigecycline resistance among multidrug-resistant Klebsiella pneumoniae: A nested case-control study
Masayuki... -
MMWR Morb Mortal Wkly Rep. Notes from the Field: Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase ? Denver, Colorado, 2012
[Source: US Centers for Disease Control and Prevention, MMWR Morbidity and Mortality Weekly Report, full page: (LINK). Edited.]
Notes from the Field: Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase... -
Antimicrob Agents Chemother. Tigecycline Does Not Prolong QTc Intervals in Healthy Subjects
[Source: Antimicrobial Agents and Chemotherapy, full page: (LINK). Abstract, edited.]
Tigecycline Does Not Prolong QTc Intervals in Healthy Subjects...
Joan M. Korth-Bradley 1,#, Paul C. McGovern 1, Joanne Salageanu 2, Kyle -
Antimicrob Agents Chemother. A Randomized Phase 2 Trial to Evaluate the Clinical Efficacy of Two High Tigecycline Dosage Regimens Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia
[Source: Antimicrobial Agents and Chemotherapy, full text: (LINK). Abstract, edited.]
A Randomized Phase 2 Trial to Evaluate the Clinical Efficacy of Two High Tigecycline Dosage Regimens Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia... -
Antimicrob Agents Chemother. Activity of fosfomycin, tigecycline, colistin and gentamicin against extended spectrum beta-lactamase (ESBL)-producing E. coli in a foreign-body infection model
[Source: Antimicrob Agents Chemother., full page: (LINK). Abstract, edited.]
Activity of fosfomycin, tigecycline, colistin and gentamicin against extended spectrum beta-lactamase (ESBL)-producing E. coli in a foreign-body infection model... -
Antimicrob Agents Chemother. The therapeutic effect of tigecycline is not influenced by the ESBL character of the Klebsiella pneumoniae strain in experimental pneumonia in rats, in contrast to ceftazidime.
[Source: Antimicrobial Agents and Chemotherapy, full text: (LINK). Abstract, edited.]
The therapeutic effect of tigecycline is not influenced by the ESBL character of the Klebsiella pneumoniae strain in experimental pneumonia in rats, in contrast... -
Antimicrob Agents Chemother. Tigecycline Displays In Vivo Bactericidal Activity against ESBL+ Enterobacteriaceae after 72 hour Exposure Period
[Source: Antimicrobial Agents and Chemotherapy, full text: (LINK). Abstract, edited.]
Tigecycline Displays In Vivo Bactericidal Activity against ESBL<SUP>+</SUP> Enterobacteriaceae after 72 hour Exposure Period
Pamela... -
The Lancet. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
[Source: The Lancet, full text: (LINK). Abstract, edited.]
...
The Lancet Infectious Diseases, Volume 11, Issue 11, Pages 834 - 844, November 2011 ? doi:10.1016/S1473-3099(11)70177-3 - Published Online: 25 July 2011
Efficacy -
The Lancet. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
[Source: The Lancet, full text: (LINK). Abstract, edited.]
...
The Lancet Infectious Diseases, Early Online Publication, 25 July 2011 doi:10.1016/S1473-3099(11)70177-3
Cite or Link Using DOI
Efficacy and safety of tigecycline -
Emerg Infect Dis. New Delhi Metallo-β-Lactamase, Ontario, Canada
New Delhi Metallo-β-Lactamase, Ontario, Canada (Emerg Infect Dis., extract, edited)
[Source: US Centers for Disease Control and Prevention, Emerging Infectious Diseases Journal, full text: <cite cite="http://www.cd... -
Lancet Infect Dis. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
The Lancet Infectious Diseases, Early Online Publication, 11 August 2010
doi:10.1016/S1473-3099(10)70143-2Cite or Link Using DOI
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological,...